AI assistant
Embla Medical hf — Director's Dealing 2017
Feb 28, 2017
8210_rns_2017-02-28_d9ba0cf6-16b0-4475-bf05-0af63a827ead.html
Director's Dealing
Open in viewerOpens in your device viewer
Ossur Hf : insider trading
Ossur Hf : insider trading
Announcement Össur hf. No. 17/2017
Reykjavík, 28 February 2017
Auðkenni útgefanda/Trade ticker:
OSSR
Nafn útgefanda/Issuer:
Össur hf.
Dagsetning tilkynningar/Date of announcement:
28 February 2017
Nafn fruminnherja/Name primary insider:
William Demant Invest A/S
Tengsl fruminnherja við útgefanda/Insider's relation with the issuer:
Niels Jacobsen
Dagsetning viðskipta/Date of transaction:
28 February 2017
Tímasetning viðskipta/Time of transaction:
16:03 CET
Tegund fjármálagernings/Type of financial instrument:
Equities
Kaup eða sala/Buy or Sell:
Buy
Fjöldi hluta/Number of shares:
2,000,000
Verð pr. Hlut/Price per share:
DKK 26.45
Fjöldi hluta í eigu fruminnherja eftir viðskipti/Primary insider's holdings
after the transaction:
190,960,514
Fjöldi hluta sem fruminnherji á kauprétt að/Primary insider's option holdings
after the transaction:
0
Fjöldi hluta fjárhagslega tengdra aðila eftir viðskipti/Related parties'
holdings after the transaction:
0
Dagsetning lokauppgjörs*/Date of settlement*:
2 March 2017
Athugasemdir*/Comments*:
Niels Jacobsen is the chairman of the Össur Board of Directors.
[]